BIOMARIN PHARMACEUTICAL INC

BMRN · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $10.4B · 3,221 employees
163
SEC Filings
$65.68
Close 2026-09-11
1
Transcripts
3,221
Employees

Business Summary

BioMarin Pharmaceutical Inc. is a global rare disease biotechnology company founded in 1997 and headquartered in San Rafael, California. The company develops and commercializes therapies for genetically defined conditions, with eight commercial products including VOXZOGO for achondroplasia, enzyme therapies VIMIZIM, NAGLAZYME, ALDURAZYME, and BRINEURA, as well as PALYNZIQ and KUVAN for PKU. BioMarin reported $3.2 billion in total revenues in 2025, driven significantly by VOXZOGO expansion.

Latest Stock Quote

BMRN 2026-09-11 $65.68 O:$65.96 H:$66.05 L:$65.285 Vol:1.6M VWAP:$65.5893
origin leaf: null

Next Earnings

expected 2026-11-17

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionBMRNdiscussed Blockchain & Crypto
topic_mentionBMRNdiscussed Semiconductor
topic_mentionBMRNdiscussed Supply Chain
topic_mentionBMRNdiscussed Regulation
topic_mentionBMRNdiscussed Automotive
topic_mentionBMRNdiscussed Healthcare & Bio
metricBMRN gross marginreported $12.7 percent
metricBMRN EPSreported $1.80

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001048477-26-000004EDGAR86K words
2025-02-242024-12-310001048477-25-000007EDGAR82K words
2024-02-262023-12-310001048477-24-000016EDGAR82K words
2023-02-272022-12-310001048477-23-000009EDGAR89K words
2022-02-252021-12-310001048477-22-000012EDGAR—
2021-02-262020-12-310001048477-21-000008EDGAR—
2020-02-272019-12-310001048477-20-000009EDGAR—
2019-02-282018-12-310001564590-19-005033EDGAR—
2018-02-262017-12-310001564590-18-003114EDGAR—
2017-02-272016-12-310001564590-17-002483EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-062026-06-300001048477-26-000016EDGAR51K words
2025-10-282025-09-300001048477-25-000107EDGAR45K words
2025-08-052025-06-300001048477-25-000090EDGAR45K words
2025-05-022025-03-310001048477-25-000051EDGAR42K words
2024-10-312024-09-300001048477-24-000152EDGAR45K words
2024-08-052024-06-300001048477-24-000126EDGAR45K words
2024-04-262024-03-310001048477-24-000070EDGAR42K words
2023-11-022023-09-300001048477-23-000044EDGAR49K words
2023-08-022023-06-300001048477-23-000029EDGAR49K words
2023-04-282023-03-310001048477-23-000020EDGAR46K words
2022-10-282022-09-300001048477-22-000033EDGAR50K words
2022-08-042022-06-300001048477-22-000027EDGAR49K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-09-150001628280-26-061973EDGAR0K words
2026-09-140001628280-26-061717EDGAR1K words
2026-09-010001193125-26-377696EDGAR1K words
2026-08-310001193125-26-375275EDGAR1K words
2026-08-180001193125-26-354780EDGAR2K words
2026-08-060001048477-26-000015EDGAR8K words
2026-03-160001193125-26-107314EDGAR1K words
2026-02-230001048477-26-000002EDGAR8K words
2026-02-120001193125-26-048736EDGAR1K words
2026-01-290001193125-26-029401EDGAR1K words

163 total filings indexed. 131 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Earnings Transcripts

Call DateQuarterTitle
— BMRN Earnings Call Transcript

Access full transcripts via API (JSON) — includes speakers, key metrics, competitive mentions, and origin provenance chain.

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

rare-disease genetic-disorders achondroplasia mucopolysaccharidosis phenylketonuria hemophilia neuronal-ceroid-lipofuscinosis fabry-disease late-onset-pompe-disease

Company Identity

CIK0001048477
TickerBMRN
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
HeadquartersSan Rafael, California
Websitehttps://www.biomarin.com
Listed1999-07-23

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 256c810713121f2be60473113f18d1a38869f734f42f2db520d634923e2770df
parent: d46ec8dd283af280de6b5bfae7a5f015a55271e6b842e780e4538cef224acc19
content hash: 3f3bad5264fb1e1feb9a21199fe07df44fab771557c5868357049efc6082045f
signed: 2026-09-30T19:00:33.742Z
sources: 23 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up BMRN using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on BMRN, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/BMRN (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.